Ph.D. Daniel Billen - 21 May 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Daniel Billen, Ph.D.
Issuer symbol
AUPH
Transactions as of
21 May 2024
Net transactions value
-$30,146
Form type
4
Filing time
22 May 2024, 16:14:25 UTC
Previous filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Sale $30,146 -5,252 -16% $5.74 28,141 21 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023.